XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating activities:    
Net loss $ (30,001) $ (41,101)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 61 208
Noncash interest expense 5,002 2,555
Share-based compensation expense 3,678 3,402
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 2,994 316
Other assets (12) (240)
Accounts payable (1,456) 3,126
Accrued expense (407) (374)
Other liabilities (130) 0
Cash used in operating activities (20,271) (32,108)
Investing activities:    
Purchases of short-term investments (34,529) (7,167)
Proceeds from sales of short-term investments 51,160 36,000
Purchase of property and equipment (20) (205)
Cash provided by investing activities 16,611 28,628
Financing activities:    
Proceeds from royalty purchase agreement 0 20,000
Proceeds from the sale of common stock, net of issuance costs 1,117 5,718
Proceeds from exercise of stock options 60 355
Cash provided by financing activities 1,177 26,073
Net decrease in cash and cash equivalents (2,483) 22,593
Cash and cash equivalents at beginning of period 19,859 15,872
Cash and cash equivalents at end of period 17,376 38,465
Supplemental schedule of non-cash investing and financing activities:    
Deferred offering costs included in accounts payable and accrued expenses 0 98
Purchase of property and equipment included in accounts payable and accrued expenses $ 0 $ 5